Katcher H, Hill A, Lanford J, Yoo J, Kris-Etherton P
doi: 10.1016/j.cmet.2021.12.010 Summary Keywords GIP, GLP-1, obesity, weight loss, tirzepatide, GLP-1R agonists, GIP receptor agonists, Citation Zaffina I, Pelle MC, Armentaro G, Giofr F, Cassano V, Sciacqua A and Arturi F (2023) Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
In cosmetics, it is an emollient
Emerging evidence regarding IL-33 and Wnt/-catenin crosstalk may hold the key to unraveling the complex pathogenesis of EMs
6.1 MASLD and NASH Studies have shown that GLP-1RAs reduce hepatic fat content and improve liver histology in patients with MASLD, decreasing steatosis, ballooning necrosis, and liver enzyme levels
Supplementary data The following are the Supplementary data to this article: References 1.Meldrum D.R., Morris M.A., Gambone J.C